Biotech Essentials

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 03.11.2021.

Ribosome
Transcription
Biotechnology
Medicine
RNA
Fertile Crescent

Companies And Industries

@kiranshaw shared
On Nov 1, 2021
Researchers @MIT & @Harvard have designed a way to selectively turn on gene therapies in target cells, including human cells. https://t.co/06zgmS5LX2
Open
Engineers devise a way to selectively turn on RNA therapies in human cells

Engineers devise a way to selectively turn on RNA therapies in human cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene expression in target cells, including human cells. Their technology can detect specific mRNA ...

@kiranshaw shared
On Nov 2, 2021
Researchers @wyssinstitute & @MIT have designed new mRNA tech that makes it possible to selectively turn on gene therapies in target cells by harnessing small, versatile devices called eToeholds, which enable expression of a linked protein-coding sequence. https://t.co/awqFAv1RNU
Open
mRNA eToehold Tech Could Enable Targeted RNA Therapeutics, Diagnostics, and Cell Sensing

mRNA eToehold Tech Could Enable Targeted RNA Therapeutics, Diagnostics, and Cell Sensing

Researchers suggest RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.

@FierceBiotech shared
On Nov 1, 2021
Zaks is treading a well-worn path between biopharma and OrbiMed, with Kevin Koch, Ph.D., Sevgi Gurkan, M.D., and Jim Sullivan, Ph.D., joining from, respectively, Biogen, Merck and AbbVie in recent years https://t.co/aoEM9v6HrU
Open
Zaks, fresh from making millions at Moderna, takes venture partner post at OrbiMed

Zaks, fresh from making millions at Moderna, takes venture partner post at OrbiMed

Tal Zaks has revealed his next job. Weeks after leaving Moderna, Zaks has taken up a venture partner post at OrbiMed—where he is joined by another storied biopharma executive.

@GENbio shared
On Nov 1, 2021
RT @xiaofei_lin: "Normally as women, we don’t have that expectation of recognition...We’re trained from childhood to constantly credit everyone else...That’s fine — but then don’t forget to credit yourself too." Check out my interview with @kiana_aran via @ClinicalOMICs! https://t.co/J27HmJHrSE
Open
CRISPR-Chip Inventor Wins Nature Women in Science Award

CRISPR-Chip Inventor Wins Nature Women in Science Award

The award provides the winner $40,000 and aims to celebrate the achievements of women in science and all those who work to support women to stay in STEM careers around the world.

@BioWorld shared
On Oct 29, 2021
Four more IPOs make strides as a powerful 2021 nears its close https://t.co/AVZVPKM4Kz
Open
Four more IPOs make strides as a powerful 2021 nears its close

Four more IPOs make strides as a powerful 2021 nears its close

Entrada Therapeutics Inc. is the largest of four biopharmas making new moves on IPOs as the company upsized its offer from 7.5 million to 9.07 million shares priced at $20 each. Last year ...

@matthewherper shared
On Nov 2, 2021
Democrats' new drug pricing outline includes carveout for small biotech https://t.co/dxyDN1c4at
Open
Democrats circulate a new drug pricing outline with a big carveout for small biotechs

Democrats circulate a new drug pricing outline with a big carveout for small biotechs

A drug pricing compromise circulating on Capitol Hill and in lobbying circles this week includes a generous carveout for small biotechs.

@NatureBiotech shared
On Nov 3, 2021
Researchers: Origins of modern wheat may provide clues to making it stronger #NBTintheNews via @upi https://t.co/OKalMTVNpq
Open
Researchers: Origins of modern wheat may provide clues to making it stronger

Researchers: Origins of modern wheat may provide clues to making it stronger

Modern wheat bread may have originated in the Caucuses region of present-day Georgia in eastern Europe, a study published Monday by Nature Biotechnology found.

@biospace shared
On Oct 29, 2021
BioSpace movers & shakers, Oct. 29 https://t.co/sBlWwGjLJc
Open
BioSpace Movers & Shakers, Oct. 29

BioSpace Movers & Shakers, Oct. 29

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.